Genetic analysis of integrin function in man: LAD-1 and other syndromes

Matrix Biology

Volumn 19, Issue 3, 2000, Pages 211-222

  Hogg, Nancy ^a   Bates, Paul A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Disease; Integrin; Mutation; Structure

Indexed keywords

BETA1 INTEGRIN; CD11 ANTIGEN; CD18 ANTIGEN; INTEGRIN; INTEGRIN BETA2 SUBUNIT; MEMBRANE RECEPTOR; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE INHERITANCE; BINDING SITE; CATTLE; CELL ADHESION; DOG; EPIDERMOLYSIS BULLOSA HEREDITARIA; GENE MUTATION; GENETIC ANALYSIS; GLANZMANN DISEASE; HEMIDESMOSOME; HUMAN; LEUKOCYTE ADHESION DEFICIENCY; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW;

EID: 0034233731     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(00)00066-4     Document Type: Short Survey

References (79)

1. Anderson D.C., Springer T.A. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1 and p150,95 glycoproteins. Ann. Rev. Med. 38:1987;175-187.
2. Anderson D.C., Finegold M.J., Schmalsteig F.C. et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J. Infect. Dis. 152:1985;668-689.
3. Anderson D.C., Kishimoto T.K., Smith C.W. Leukocyte adhesion deficiency and other disorders of leukocyte adherence and motility. Scriver C.R., Beaudet A.L., Sly A.L., Valle D. The Metabolic and Molecular Bases of Inherited Disease, vol. III. 1997;3955-3994 McGraw-Hill, Inc, New York.
4. Arnaout M.A., Michishita M. Gupta S., Griselli C. Genetic Abnormalities in Leukocyte Adhesion Molecule Deficiency. New Concepts in Immunodeficiency Diseases. 1993;190-200 J. Wiley and Sons, USA.
5. Back A.L., Kwok W.W., Hickstein D.D. Identification of two molecular defects in a child with leukocyte adherence deficiency. J. Biol. Chem. 267:1992;5482-5487.
6. 3 integrin. J. Biol. Chem. 269:1994;20913-20919.
7. 2, CD11b/CD18). J. Biol. Chem. 270:1995;94-98.
8. Bates P.A., Sternberg M.J. Model building by comparison at CASP3: using expert knowledge and computer automation. Proteins. 37:1999;47-54.
9. Burgeson R.E., Christiano A.M. The dermal-epidermal junction. Curr. Opin. Cell Biol. 9:1997;651-658.
10. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
11. Chen Y.P., Djaffar I., Pidard D. et al. Ser-752→Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10169-10173.
12. Corbi A.L., Vara A., Ursa A., Garcia Rodriguez M.C., Fontan G., Sanchez-Madrid F. Molecular basis for a severe case of leukocyte adhesion deficiency. Eur. J. Immunol. 22:1992;1877-1881.
13. D'Souza S.E., Ginsberg M.H., Burke T.A., Lam S.C.-T., Plow E.F. Localisation of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science. 242:1988;91-93.
14. 3 subunit: cation displacement is involved in ligand binding. Cell. 79:1994;659-667.
15. Etzioni A., Frydman M., Pollack S. et al. Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med. 327:1992;1789-1792.
16. Fischer, A., Descamps-Latscha, B., Gerota, I. et al., 1983. Bone marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis and oxidative response during opsonised particle phagocytosis. Lancet 2 8348, 473-476.
17. Fitzgerald L.A., Steiner B., Rall S.C. Jr., Lo S.S., Phillips D.R. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to 'integrin'. J. Biol. Chem. 262:1987;3936-3939.
18. French D.L., Coller B.S. Haematologically important mutations: Glanzmann thrombasthenia. Blood Cells Mol. Dis. 23:1997;39-51.
19. Gagnoux-Palacios L., Gache Y., Ortonne J.P., Meneguzzi G. Hemidesmosome assembly assessed by expression of a wild-type integrin beta 4 cDNA in junctional epidermolysis bullosa keratinocytes. Lab. Invest. 77:1997;459-468.
20. Gahmberg C.G., Tolvanen M., Kotovuori P. Structure and function of human leukocyte β2 integrins and their cellular ligands. Eur. J. Biochem. 245:1997;215-232.
21. Georges-Labouesse E., Messaddeq N., Yehia G., Cadalbert L., Dierich A., Le Meur M. Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nat. Genet. 13:1996;370-373.
22. Giancotti F.G. Signal transduction by the alpha 6 beta 4 integrin: charting the path between laminin binding and nuclear events. J. Cell Sci. 109:1996;1165-1172.
23. Giger U., Boxer L.A., Simpson P.J., Lucchesi B.R., Todd R.F. Deficiency of leukocyte surface glycoproteins Mo1, LFA-1, and Leu M5 in a dog with recurrent bacterial infections: an animal model. Blood. 69:1987;1622-1630.
24. Goodman T.G., Bajt M.L. Identifying the putative metal ion-dependent adhesion site in the β2 (CD18) subunit required for αLβ2 and αMβ2 ligand interactions. J. Biol. Chem. 271:1996;23729-23736.
25. Grakoui A., Bromley S.K., Sumen C. et al. The immunological synapse: a molecular machine controlling T cell activation. Science. 285:1999;221-227.
26. Hodivala-Dilke K.M., McHugh K.P., Tsakiris D.A. et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103:1999;229-238.
27. Hogervorst F., Kuikman I., von dem Borne A.E., Sonnenberg A. Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kd cytoplasmic domain. EMBO J. 9:1990;765-770.
28. Hogervorst F., Koikman I., von Kessel A.G., Sonnenberg A. Molecular cloning of the human α6 integrin subunit. Alternative splicing of α6 mRNA and chromosomal localization of the α6 and β4 genes. Eur. J. Biochem. 199:1991;425.
29. Hogg N., Stewart M.P., Scarth S.L. et al. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J. Clin. Invest. 103:1999;97-106.
30. Huang C., Springer T.A. A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule-1 (ICAM-1). J. Biol. Chem. 270:1995;19008-19016.
31. Huang C., Springer T.A. Folding of the beta-propeller domain of the integrin alpha-L subunit is independent of the I domain and dependent on the beta 2 subunit. Proc. Natl. Acad. Sci. 94:1997;3167.
32. Hughes P.E., Diaz-Gonzalez F., Leong L. et al. Breaking the integrin hinge. J. Biol. Chem. 271:1996;6571-6574.
33. Karsan A., Cornejo C.J., Winn R.K. et al. Leukocyte adhesion deficiency type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium. J. Clin. Invest. 101:1998;2438-2445.
34. Kijas J.M., Bauer T.R. Jr., Gafvert S. et al. A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics. 61:1999;101-107.
35. Kishimoto T.K., Hollander N., Roberts T.M., Anderson D.C., Springer T.A. Heterogeneous mutations in the β subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell. 50:1987;193-202.
36. Kishimoto T.K., O'Connor K., Lee A., Roberts T.M., Springer T.A. Cloning of the β subunit of the leukocyte adhesion proteins: homology to an extracellular matrix receptor defines a novel supergene family. Cell. 48:1987;681-690.
37. Kuijpers T.W., Van Lier R.A.W., Hamann D. et al. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. J. Clin. Invest. 100:1997;1725-1733.
38. Law S.K.A., Gagnon J., Hildreth J.E.K., Wells C.E., Willis A.C., Wong A.J. The primary structure of the β-subunit of the cell surface adhesion glycoproteins LFA-1, CR3 and p150,95 and its relationship to the fibronectin receptor. EMBO J. 6:1987;915-919.
39. Lee J.-O., Bankston L.A., Arnaout M.A., Liddington R.C. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure. 3:1995;1333-1340.
40. Lee J.-O., Rieu P., Arnaout M.A., Liddington R. Crystal structure of the A-domain from the α-subunit of integrin CR3 (CD11b/CD18). Cell. 80:1995;631-638.
41. Leitinger B., Hogg N. Integrin I domains and their function. Biochem. Soc. Trans. 27:1999;826-832.
42. 2+-complexed crystal structures. J. Cell Biol. 143:1998;1523-1534.
43. Loftus J.C., Liddington R.C. New insights into integrin-ligand interaction. J. Clin. Invest. 99:1997;2302-2306.
44. 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science. 249:1990;915-918.
45. Lopez Rodriguez C., Nueda A., Grospierre B. et al. Characterization of two new CD18 alleles causing severe leukocyte adhesion deficiency. Eur. J. Immunol. 23:1993;2792-2798.
46. Lu C., Oxvig C., Springer T.A. The structure of the beta-propeller domain and C-terminal region of the integrin alphaM subunit. Dependence on beta subunit association and prediction of domains. J. Biol. Chem. 273:1998;15138-15147.
47. Marquardt T., Brune T., Luhn K. et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J. Pediatr. 134:1999;681-688.
48. McDowall A., Leitinger B., Stanley P., Bates P.A., Randi A.M., Hogg N. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1). J. Biol. Chem. 27:1998;396-403.
49. Newman P.J., Poncz M. Inherited disorders of platelets. Scriver C.R., Beaudet A.L., Sly A.L., Valle D. The Molecular Bases of Inherited Disease, vol. III. 1997;3335-3366 McGraw-Hill, Inc, New York.
50. Newman P.J., Seligsohn U., Lyman S., Coller B.S. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3160-3164.
51. Nievers M.G., Schaapveld R.Q., Sonnenberg A. Biology and function of hemidesmosomes. Matrix Biol. 18:1999;5-17.
52. Oxvig C., Lu C., Springer T.A. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2215-2220.
53. Petty H.R., Todd III R.F. Integrins as promiscuous signal transduction devices. Immunol. Today. 17:1996;209-212.
54. Poncz M., Eisman R., Heidenreich R. et al. Structure of the platelet membrane glycoprotein IIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. J. Biol. Chem. 262:1987;8476-8482.
55. Pulkkinen L., Uitto J. Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol. 18:1999;29-42.
56. Pulkkinen L., Kimonis V.E., Xu Y., Spanou E.N., McLean W.H.I., Uitto J. Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum. Mol. Genet. 6:1997;669-674.
57. Pulkkinen L., Bruckner-Tuderman L., August C., Uitto J. Compound heterozygosity for missense (L156P) and nonsense (R554X) mutations in the beta4 integrin gene (ITGB4) underlies mild, nonlethal phenotype of epidermolysis bullosa with pyloric atresia. Am. J. Pathol. 152:1998;935-941.
58. Pulkkinen L., Kim D.U., Uitto J. Epidermolysis bullosa with pyloric atresia: novel mutations in the beta4 integrin gene (ITGB4). Am. J. Pathol. 152:1998;157-166.
59. Ruzzi L., Gagnoux-Palacios L., Pinola M. et al. A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J. Clin. Invest. 99:1997;2826-2831.
60. Schaapveld R.Q., Borradori L., Geerts D. et al. Hemidesmosome formation is initiated by the beta4 integrin subunit, requires complex formation of beta4 and HD1/plectin, and involves a direct interaction between beta4 and the bullous pemphigoid antigen 180. J. Cell Biol. 142:1998;271-284.
61. Scharffetter-Kochanek K., Lu H., Norman K. et al. Spontaneous skin ulceration and defective T cell function in CD18 null mice. J. Exp. Med. 188:1998;119-131.
62. Shuster D.E., Kehrli M.E., Ackermann M.R., Gilbert R.O. Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle. Proc. Natl. Acad. Sci. U.S.A. 89:1992;9225-9229.
63. Sligh J.E. Jr., Hurwitz M.Y., Zhu C.M., Anderson D.C., Beaudet A.L. An initiation codon mutation in CD18 in association with the moderate phenotype of leukocyte adhesion deficiency. J. Biol. Chem. 267:1992;714-718.
64. Smith J.W., Cheresh D.A. The Arg-Gly-Asp binding domain of the virtonectin receptor. Photoaffinity cross-linking implicates amino acid residues 61-203 of the β subunit. J. Biol. Chem. 263:1988;18726-18731.
65. Springer T.A. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain. Proc. Natl. Acad. Sci. U.S.A. 94:1997;65-72.
66. Springer T.A., Scott Thompson W., Miller L.J., Schmalstieg F.C., Anderson D.C. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J. Exp. Med. 137:1984;15-27.
67. Stewart M., Hogg N. Regulation of leukocyte integrin function: affinity vs. avidity. J. Cell. Biochem. 61:1996;554-561.
68. Suzuki S., Naitoh Y. Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells. EMBO J. 9:1990;757-763.
69. Tamura R.N., Rozzo C., Starr L. et al. Epithelial integrin alpha 6 beta 4: complete primary structure of alpha 6 and variant forms of beta 4. J. Cell Biol. 111:1990;1593-1604.
70. 3 is dependent on a MIDAS-like domain in the β3 subunit. J. Biol. Chem. 271:1996;21978-21984.
71. Tuckwell D.S., Humphries M.J. A structure prediction for the ligand-binding region of the integrin beta subunit: evidence for the presence of a von Willebrand factor A domain. FEBS Lett. 400:1997;297-303.
72. van der Neut R., Krimpenfort P., Calafat J., Niessen C.M., Sonnenberg A. Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice. Nat. Genet. 13:1996;366-369.
73. Vidal F., Aberdam D., Miquel C. et al. Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat. Genet. 10:1995;229-234.
74. Wang R., Shattil S.J., Ambruso D.R., Newman P.J. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signalling through the integrin alpha11b beta3 complex. J. Clin. Invest. 100:1997;2393-2403.
75. Weisel J.W., Nagaswami C., Vilaire G., Bennett J.S. Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J. Biol. Chem. 267:1992;16637-16643.
76. Weitzman J.B., Wells C.E., Wright A.H., Clark P.A., Law S.K.A. The gene organisation of the human β2 integrin subunit (CD18). FEBS Lett. 294:1991;97-103.
77. Wright A.H., Douglass W.A., Taylor G.M. et al. Molecular characterization of leukocyte adhesion deficiency in six patients. Eur. J. Immunol. 25:1995;717-722.
78. Zhang L., Plow E.F. Overlapping, but not identical, sites are involved in the recognition of C3bi, neutrophil inhibitory factor, and adhesive ligands by the αMβ2 integrin. J. Biol. Chem. 271:1996;18211-18216.
79. Zimrin A.B., Gidwitz S., Lord S. et al. The genomic organization of platelet glycoprotein IIIa. J. Biol. Chem. 265:1990;8590-8595.